StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Pyridine → N-(3-chloro-4-fluorophenyl)-2-[1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetamide

HRID 880123
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 880123
N1C=CC=CC=1.Cl.CN(C)CCCN=C=NCC.[Cl:19][C:20]1[CH:21]=[C:22]([CH:24]=[CH:25][C:26]=1[F:27])[NH2:23].[CH3:28][N:29]1[C:34](=[O:35])[CH:33]=[C:32]([N:36]2[CH2:41][CH2:40][O:39][CH2:38][CH2:37]2)[N:31]=[C:30]1[CH2:42][C:43]([O-])=[O:44].[Na+]>CN(C)C=O>[Cl:19][C:20]1[CH:21]=[C:22]([NH:23][C:43](=[O:44])[CH2:42][C:30]2[N:29]([CH3:28])[C:34](=[O:35])[CH:33]=[C:32]([N:36]3[CH2:41][CH2:40][O:39][CH2:38][CH2:37]3)[N:31]=2)[CH:24]=[CH:25][C:26]=1[F:27]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 4

HCID 1049PyridineHCID 97083-Chloro-4-fluoroanilineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 57523684Sodium [1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate

Produkt 1

HCID 66553214N-(3-chloro-4-fluorophenyl)-2-[1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetamide
Ausbeute 27,5 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

120 ml of pyridine, 182 mg of N-[3-(dimethylamino)propyl]-N′-ethylcarbodiimide hydrochloride and 210 mg of 3-chloro-4-fluoroaniline are added to a solution of 200 mg of sodium [1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate in 2.5 ml of N,N-dimethylformamide. The reaction mixture is stirred at ambient temperature overnight and is then concentrated under reduced pressure. Water is added, followed by extraction with ethyl acetate, further washing with water, and concentration under reduced pressure. The residue obtained is washed with ethyl acetate and then rinsed with ethyl ether. 76 mg of N-(3-chloro-4-fluorophenyl)-2-[1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetamide are obtained in the form of a violet solid, the characteristics of which are the following:

Aufarbeitung

  1. concentrationis then concentrated under reduced pressure
  2. additionWater is added
  3. extractionfollowed by extraction with ethyl acetate
  4. washfurther washing with water, and concentration under reduced pressure
  5. customThe residue obtained
  6. washis washed with ethyl acetate
  7. washrinsed with ethyl ether

Quellen und Nachweise

ORD-Eintrag
ord-6b36852126764cd69485f111b5e556db
Quelldatensatz
uspto-grants-2015_03
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08993565B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion